Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home > Basic Research > Faculty > Paula M. Chilton, Ph.D.

Paula M. Chilton, Ph.D.

by Eaves JR,Baxter Slaten last modified Nov 03, 2010 11:15 AM

Paula Chilton, Ph.D.

Assistant Professor, Dept. of Microbiology & Immunology

Ph.D. University of Louisville, 1996

B.S. Western Kentucky University 1991

 

Research Interests

  • Effects of low-toxicity TLR-based adjuvants on T cell differentiation, function and survival
  • Vaccination and the induction of T cell memory

 

Professional Bio

2009 - present 
Assistant Professor of Microbiology & Immunology University of Louisville School of Medicine Institute for Cellular Therapeutics
2003 - 2009
Research Associate University of Louisville School of Medicine Institute for Cellular Therapeutics
1999 - 2003
Postdoctoral Fellow, University of Louisville School of Medicine Institute for Cellular Therapeutics
1996 - 1999
Postdoctoral Fellow in Clinical Studies University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA
                              

 

Selected Publications

M. Mühlbauer, PM Chilton, TC Mitchell and C Jobin.  Impaired Bcl3 up-regulation leads to enhanced LPS-induced IL-23p19 gene expression in IL-10-/- mice. Journal of Biological Chemistry, 2008; 283:14182-9.  PMID: 18375954.

 

V Mata-Haro, C Cekic, M Martin, PM Chilton, CR Casella and TC Mitchell.. The vaccine adjuvant monophosphoryl Lipid A as a TRIF-biased agonist of TLR4.  Science, 2007; 316:1628-32.  PMID: 17569868

 

S Sengupta, P Jayaraman, PM Chilton, CR Casella and TC Mitchell. Unrestrained GSK-3β activity leads to activated T cell death and can be inhibited by natural adjuvant. Journal of Immunology, 2007; 178:6083-91.  PMID: 17475833

 

PM Chilton and TC Mitchell. CD8 T cells require Bcl-3 for maximal gamma interferon production upon secondary exposure to antigen.  Infection and Immunity, 2006; 74: 4180-9.  PMID: 16790793.

 

PM Chilton, F Rezzoug, M Ratajczak, I Fugier-Vivier, J Ratajczak, M Kucia, Y Huang, MK Tanner and ST Ildstad.  Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients. Blood, 2005; 105:2189-97.  PMID: 15522953.

 

PM Chilton, F Rezzoug, I Fugier-Vivier,  LA Weeter, H Xu, Y Huang, MB Ray and  ST Ildstad.  Flt3-ligand treatment prevents diabetes in NOD mice. Diabetes 2004; 53:1995-2002. PMID: 15277378.

 

RW Sweeney, J Uzonna, RH Whitlock, PL Habecker, P Chilton and P Scott..  Tissue predilection sites and effect of dose of Mycobacterium avium subs. paratuberculosis organism recovery in a short-term bovine experimental oral infection model.  Res Vet Sci 2006; 80: 253-259.  PMID: 16165171.

 

 

Document Actions
Personal tools